Lies and medicine

Pharmaceutical companies have once again started a campaign to push for an increase in the price of common medicines


Kamal Siddiqi March 20, 2016
The writer is Editor of The Express Tribune

Last month on a visit to Bangladesh, a doctor was contacted to prescribe some medicine for a toothache. The doctor prescribed a pain-killer which, when arrived, turned out to be a generic drug with a local name. It did the job fine, although when compared in terms of price to what is offered by multinationals in the Pakistan market, it was at a fraction of the cost.

Further inquiries to my friend Kaiser Kabir, who runs the Bangladeshi pharma company Renata, showed how the industry in that country has made great strides over the years not only in terms of producing generic medicines at affordable prices but how it has also invested heavily in research. Leave aside that, Bangladesh has been exporting pharma raw material to a number of developing countries including Pakistan as well as exporting cancer fighting drugs to the West and the US.

One is reminded of Sheikh Mohammad Rashid, one of the founding fathers of the Pakistan Peoples Party (PPP), who was regarded as an ideologue by thousands of PPP activists and was committed to a socialist cause. This had earned him a reputed nickname in Lahore as Baba-e-Socialism. Rashid wanted to introduce the system of generic drugs so that Pakistanis could have access to cheap and quality medicines and not be held hostage by multinational pharma companies. Sadly this was not to be.

This week, pharmaceutical companies in Pakistan have once again started a campaign to push for an increase in the already inflated price of common medicines. And given the corruption that we see in the ministry of health and the notoriously corrupt Drug Regulatory Authority of Pakistan (DRAP), we can expect yet another price hike anytime soon.

Hitler’s minister of propaganda once said that if a lie is repeated time and again, the people would start to accept it as the truth. This is the case in terms of the points that the pharma companies are making to press for an increase in prices.

In its media campaign the pharma industry insists that the price of drugs in Pakistan is cheaper than in neighbouring countries. This is false. Iran, India and Bangladesh produce and sell drugs at a fraction of the cost at which we do. The argument that they have a bigger market is also untrue, because the market in Iran and Bangladesh is smaller than ours.

While control prices remain static in some instances, it is also not true that they have gone unfluctuated for 13 years. Ask any chemist and they will tell you how prices are regularly changed and also how shortages are created so that some drugs are then sold at black market rates. Drug names are changed and medicines are re-marketed, and in some instances discontinued only because the government does not agree at times to exorbitant price increases.

There is almost no investment in pharma research in Pakistan. Drugs are more or less imported in bulk raw material and re-packaged and sold here at high profit margins. There is no transfer of technology either and the argument that drugs produced by certain companies have more efficacy is not usually the case.

The government looks the other way. DRAP does not investigate the unethical marketing policies introduced by some pharma companies under which doctors are given bonuses and incentives to prescribe one drug over another. Such incentives include overseas trips for “conferences.”

Almost no effort has been made by the ministry of health to stop the manufacture of fake drugs. One estimate says that one in every three drugs sold is fake. In fact, when chemists go to make bulk purchases, they have the option to buy original or fake medicines. Many opt for the second category as it assures them higher profit margins. To add to this in many chemist shops, we also see unqualified persons dispensing medicines with no check or fear. How long will this continue?

If there is any progress made, it has been by local producers. But it has been patchy and much of this has come from imports and not through indigenous effort. It is time we shamed ourselves into framing a pharmaceutical policy that allowed Pakistanis access to quality medicines at cheap and competitive prices. We cannot continue to support the corrupt system that is in place right now. Someone has to take a stand.

Published in The Express Tribune, March 21st,  2016.

Like Opinion & Editorial on Facebook, follow @ETOpEd on Twitter to receive all updates on all our daily pieces.

COMMENTS (4)

Tariq Mahmud | 5 years ago | Reply The author has made right observations as these are heavily evidence based.On my last visit to Bangla Desh in 2010 I had the same experience when I was given an incredibly cheep medicine by Pakistani standard for the stomach problem . I was hesitant to use rihad an assurance by the doctor . I safely recovered after two dozes .As a youn reporter in the early seventies I had the occasion to cover late sheikh Rashid Ahmed' Federal Health Ministers historic conference about the introduction of generic medicines in the country. The move had legislative cover and within a few months there was a turn around. The move was not viewed charitably by the multi nationals and their cohorts.Today we are deep into their strangle.. Having served at key position in Punjab and erstwhile NWFP health departments I was closely associated with the central purchase in both the departments. The pharma industry thrives on a huge margin as the labelled price is the maximum retailed price,MRP,which gives a cushion to the manufacturer and the supplier to play around. There is also a need to round of the medicine prices as the retailers more often does not return the residual amount to the customer.?sadly there is no check either .Quality and price control has to go side by side.
Munir Ahmad Kakar | 5 years ago | Reply Having observed the performance of Ministry of health one can only conclude that every Minister has consistently followed his predecessor by allowing pharma companies to escalate price but simultaneously claim that government is committed to provide affordable medicines.
VIEW MORE COMMENTS
Replying to X

Comments are moderated and generally will be posted if they are on-topic and not abusive.

For more information, please see our Comments FAQ

E-Publications

Most Read